Status:
COMPLETED
Prevalence and Associated Mortality of Infections by Multidrug-Resistant Organisms in Adults Intensive Care Units
Lead Sponsor:
Hospital Italiano de Buenos Aires
Conditions:
Infectious Disease
Eligibility:
All Genders
18+ years
Brief Summary
Observational 24-hr point prevalence study with longitudinal follow-up at 164 ICUs in Argentina. All adult patients (aged ≥18 years) at a participating ICU on November 24-28, 2023 with 60- day follow-...
Detailed Description
Methods Study design PREVAR (PREValence of infection by MDR-microorganisms in ARgentina) was a national, cross-sectional, 24-hour multicentre study designed and conducted by SADI and SATI in Argentine...
Eligibility Criteria
Inclusion
- All adult patients, 18 years and older, present on a participating ICU on the study day during the 24-h period (beginning at 8.00 a.m.) were included.
Exclusion
- There were no exclusion criteria.
Key Trial Info
Start Date :
November 24 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 24 2024
Estimated Enrollment :
1799 Patients enrolled
Trial Details
Trial ID
NCT06574776
Start Date
November 24 2023
End Date
January 24 2024
Last Update
August 28 2024
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Austral
Buenos Aires, Argentina
2
Hospital de San Martin de La Plata
Buenos Aires, Argentina
3
Hospital Italiano
Buenos Aires, Argentina
4
Hospital Pirovano
Buenos Aires, Argentina